JB Chemicals & Pharmaceuticals Ltd.

₹1,961.1

-47.7 (-2.4%)

JBCHEPHARM Share Price

Pharmaceuticals & Biotechnology

As on April 2, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 31,453 Cr

P/E Ratio46.29

Dividend Yield0.79 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	2,035.26	Bearish
10-DMA	2,067.49	Bearish
20-DMA	2,080.62	Bearish
50-DMA	1,993.54	Bearish
100-DMA	1,903.74	Bullish
200-DMA	1,801.8	Bullish

Historical Performance

1 Year

25.2%

3 Years

98.5%

5 Years

213.2%

10 Years

1465.4%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	39,180	34,842	31,493	24,242	20,425
Total Expenditure	28,869	25,917	24,535	18,816	14,864
Other Income	390	417	99	401	1,166
Operating Profit	10,702	9,342	7,057	5,827	6,728
Interest	117	443	361	51	72
Depreciation	1,710	1,383	1,144	727	687
Profit Before Tax	8,874	7,515	5,552	5,049	5,969
Consolidated Net Profit	6,596	5,526	4,098	3,854	4,480
Adjusted EPS	42	36	26	25	29

Compounded Sales Growth

10 Years:27.9

5 Years:17.2

3 Years:10.1

TTM:2.4

Compounded Profit Growth

10 Years:45.7

5 Years:19.4

3 Years:11.3

TTM:3.6

Stock Price CAGR

10 Years:31.7

5 Years:25.7

3 Years:26

TTM:24.1

Return on Equity

10 Years:9.6

5 Years:29

3 Years:26.5

last year:42.4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	156	155	155	155	155
Total Reserves	32,497	27,680	23,433	20,560	17,943
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	4,432	4,660	9,920	4,753	725
Other Current Liabilities	1,373	4,358	2,403	813	898
Short Term Borrowings	138	153	280	263	326
Total Liabilities	50,335	46,770	40,981	30,691	25,725
Capital Work in Progress	467	633	444	139	256
Long Term Loans & Advances	2,759	2,936	5,143	4,351	56
Currents Investments	3,171	3,647	1,922	---	6,650
Short Term Loans and Advances	6,271	5,902	2,771	2,430	4,157
Total Current Assets	24,473	22,729	15,993	13,246	18,939
Total Assets	50,335	46,770	40,981	30,691	25,725
Adjusted Book Value	210	179	152	268	234

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 46.29, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 26.0%, indicating sustained price appreciation.
The stock carries a low beta of 0.5, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹10702 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹39180 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1240731.4

No. of Shares: 633 (Approx)

Performance:24.1%

P/L: ₹240731.4

NIFTY Performance: -2.3%

1 day Top Gainers